| Year |
Citation |
Score |
| 2022 |
Metry M, Dirda NDA, Raufman JP, Polli JE, Kao JPY. Novel nitroxide-bile acid conjugates inform substrate requirements for human bile acid transporters. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 180: 106335. PMID 36402308 DOI: 10.1016/j.ejps.2022.106335 |
0.33 |
|
| 2021 |
Metry M, Shu Y, Abrahamsson B, Cristofoletti R, Dressman JB, Groot DW, Parr A, Langguth P, Shah VP, Tajiri T, Mehta MU, Polli JE. Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Metformin Hydrochloride. Journal of Pharmaceutical Sciences. PMID 33450218 DOI: 10.1016/j.xphs.2021.01.011 |
0.305 |
|
| 2020 |
Charoo NA, Abdallah DB, Parveen T, Abrahamsson B, Cristofoletti R, Groot DW, Langguth P, Parr A, Polli JE, Mehta M, Shah VP, Tajiri T, Dressman J. Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Moxifloxacin hydrochloride. Journal of Pharmaceutical Sciences. PMID 32534881 DOI: 10.1016/J.Xphs.2020.06.007 |
0.38 |
|
| 2020 |
Plöger GF, Quizon PM, Abrahamsson B, Cristofoletti R, Groot DW, Parr A, Langguth P, Polli JE, Shah VP, Tajiri T, Mehta MU, Dressman J. Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Cephalexin Monohydrate. Journal of Pharmaceutical Sciences. PMID 32240696 DOI: 10.1016/J.Xphs.2020.03.025 |
0.389 |
|
| 2020 |
Garzel B, Hu T, Li L, Lu Y, Heyward S, Polli J, Zhang L, Huang SM, Raufman JP, Wang H. Metformin Disrupts Bile Acid Efflux by Repressing Bile Salt Export Pump Expression. Pharmaceutical Research. 37: 26. PMID 31907698 DOI: 10.1007/S11095-019-2753-X |
0.417 |
|
| 2019 |
Bransford P, Cook J, Gupta M, Haertter S, He H, Ju R, Kanodia J, Lennernäs H, Lindley D, Polli JE, Wenning L, Wu Y. ICH M9 Guideline in development on Biopharmaceutics Classification System-based biowaivers: An Industrial Perspective from the IQ Consortium. Molecular Pharmaceutics. PMID 31846335 DOI: 10.1021/Acs.Molpharmaceut.9B01062 |
0.346 |
|
| 2019 |
Liu T, Kotha RR, Jones JW, Polli JE, Kane MA. Fast liquid chromatography-tandem mass spectrometry method for simultaneous determination of eight antiepileptic drugs and an active metabolite in human plasma using polarity switching and timed selected reaction monitoring. Journal of Pharmaceutical and Biomedical Analysis. 176: 112816. PMID 31465890 DOI: 10.1016/J.Jpba.2019.112816 |
0.326 |
|
| 2018 |
Raufman JP, Metry M, Felton J, Cheng K, Xu S, Polli J. A F magnetic resonance imaging-based diagnostic test for bile acid diarrhea. Magma (New York, N.Y.). PMID 30387017 DOI: 10.1007/S10334-018-0713-9 |
0.402 |
|
| 2018 |
Zhu P, Ye Z, Guo D, Xiong Z, Huang S, Guo J, Zhang W, Polli JE, Zhou H, Li Q, Shu Y. Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2). Pharmaceutical Research. 35: 243. PMID 30361780 DOI: 10.1007/S11095-018-2526-Y |
0.372 |
|
| 2018 |
Metry M, Felton J, Cheng K, Xu S, Ai Y, Xue F, Raufman JP, Polli JE. Attenuated Accumulation of Novel Fluorine (19F)-Labeled Bile Acid Analogues in Gallbladders of Fibroblast Growth Factor-15 (FGF15)-Deficient Mice. Molecular Pharmaceutics. PMID 30247920 DOI: 10.1021/Acs.Molpharmaceut.8B00454 |
0.353 |
|
| 2018 |
Guo D, Yang H, Li Q, Bae HJ, Obianom O, Zeng S, Su T, Polli JE, Shu Y. Selective Inhibition on Organic Cation Transporters by Carvedilol Protects Mice from Cisplatin-Induced Nephrotoxicity. Pharmaceutical Research. 35: 204. PMID 30191328 DOI: 10.1007/S11095-018-2486-2 |
0.36 |
|
| 2018 |
Cheng K, Metry M, Felton J, Shang AC, Drachenberg CB, Xu S, Zhan M, Schumacher J, Guo GL, Polli JE, Raufman JP. Diminished gallbladder filling, increased fecal bile acids, and promotion of colon epithelial cell proliferation and neoplasia in fibroblast growth factor 15-deficient mice. Oncotarget. 9: 25572-25585. PMID 29876009 DOI: 10.18632/Oncotarget.25385 |
0.337 |
|
| 2018 |
Plöger GF, Abrahamsson B, Cristofoletti R, Groot DIRKW, Langguth P, Mehta MU, Parr A, Polli JE, Shah VP, Tajiri T, Dressman JB. Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Proguanil Hydrochloride. Journal of Pharmaceutical Sciences. PMID 29571740 DOI: 10.1016/J.Xphs.2018.03.009 |
0.365 |
|
| 2017 |
Oner ZG, Michel SLJ, Polli JE. Equivalence and regulatory approaches of nonbiological complex drug products across the United States, the European Union, and Turkey. Annals of the New York Academy of Sciences. PMID 29090833 DOI: 10.1111/Nyas.13505 |
0.326 |
|
| 2017 |
Hofsäss MA, Souza J, Silva-Barcellos NM, Bellavinha KR, Abrahamsson B, Cristofoletti R, Groot DW, Parr A, Langguth P, Polli JE, Shah VP, Tajiri T, Mehta MU, Dressman JB. Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Folic acid. Journal of Pharmaceutical Sciences. PMID 28842299 DOI: 10.1016/J.Xphs.2017.08.007 |
0.398 |
|
| 2017 |
Thambavita D, Galappatthy P, Mannapperuma U, Jayakody RL, Cristofoletti R, Abrahamsson B, Groot DW, Langguth P, Mehta M, Parr A, Polli JE, Shah VP, Dressman J. Biowaiver Monograph for Immediate Release Solid Oral Dosage Forms: Amoxicillin Trihydrate. Journal of Pharmaceutical Sciences. PMID 28483422 DOI: 10.1016/J.Xphs.2017.04.068 |
0.325 |
|
| 2017 |
Verbeeck RK, Kanfer I, Löbenberg R, Abrahamsson B, Cristofoletti R, Groot DW, Langguth P, Polli JE, Parr A, Shah VP, Mehta M, Dressman JB. Biowaiver monographs for Immediate Release solid oral dosage forms: Enalapril. Journal of Pharmaceutical Sciences. PMID 28435140 DOI: 10.1016/J.Xphs.2017.04.019 |
0.355 |
|
| 2017 |
Martinez MN, Mistry B, Lukacova V, Lentz KA, Polli JE, Hoag SW, Dowling T, Kona R, Fahmy RM. Exploring Canine-Human Differences in Product Performance. Part II: Use of Modeling and Simulation to Explore the Impact of Formulation on Ciprofloxacin In Vivo Absorption and Dissolution in Dogs. The Aaps Journal. PMID 28265981 DOI: 10.1208/S12248-017-0055-Y |
0.684 |
|
| 2017 |
Felton J, Metry M, Cheng K, Shang AC, Xu S, Vivian D, Polli J, Raufman J. Fluorine-Labeled Bile Acid Live-Animal Magnetic Resonance Imaging (MRI) Detects Bile Acid Malabsorption in FGF15 Knockout Mice Gastroenterology. 152: S424. DOI: 10.1016/S0016-5085(17)31639-6 |
0.614 |
|
| 2016 |
Felton J, Cheng K, Said A, Shang AC, Xu S, Vivian D, Metry M, Polli JE, Raufman JP. Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport. Journal of Visualized Experiments : Jove. PMID 27929465 DOI: 10.3791/54597 |
0.677 |
|
| 2016 |
Dickinson PA, Kesisoglou F, Flanagan T, Martinez MN, Mistry HB, Crison JR, Polli JE, Cruañes MT, Serajuddin AT, Müllertz A, Cook JA, Selen A. Optimizing Clinical Drug Product Performance: Applying Biopharmaceutics Risk Assessment Roadmap (BioRAM) and the BioRAM Scoring Grid. Journal of Pharmaceutical Sciences. PMID 27659159 DOI: 10.1016/J.Xphs.2016.07.024 |
0.315 |
|
| 2016 |
Martinez M, Mistry B, Lukacova V, Polli J, Hoag S, Dowling T, Kona R, Fahmy R. Use of Modeling and Simulation Tools for Understanding the Impact of Formulation on the Absorption of a Low Solubility Compound: Ciprofloxacin. The Aaps Journal. PMID 27116024 DOI: 10.1208/S12248-016-9913-2 |
0.422 |
|
| 2016 |
Raman S, Polli JE. Prediction of Positive Food Effect: Bioavailability Enhancement of BCS Class II Drugs. International Journal of Pharmaceutics. PMID 27067239 DOI: 10.1016/J.Ijpharm.2016.04.013 |
0.344 |
|
| 2016 |
Vaithianathan S, Haidar SH, Zhang X, Jiang W, Avon C, Dowling TC, Shao C, Kane M, Hoag SW, Flasar MH, Ting TY, Polli JE. Reply to "On the Effect of Common Excipients on the Oral Absorption of Class 3 Drugs". Journal of Pharmaceutical Sciences. 105: 1355-7. PMID 27019956 DOI: 10.1016/J.Xphs.2016.02.028 |
0.31 |
|
| 2016 |
Goodarzi N, Barazesh Morgani A, Abrahamsson B, Cristofoletti R, Groot DW, Langguth P, Mehta MU, Polli JE, Shah VP, Dressman JB. Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ribavirin. Journal of Pharmaceutical Sciences. PMID 26952879 DOI: 10.1016/J.Xphs.2016.01.017 |
0.378 |
|
| 2016 |
Li Q, Yang H, Guo D, Zhang TL, Polli JE, Zhou HH, Shu Y. Effect of Ondansetron on Metformin Pharmacokinetics and Response in Healthy Subjects. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 26825640 DOI: 10.1124/Dmd.115.067223 |
0.361 |
|
| 2015 |
Vaithianathan S, Haidar SH, Zhang X, Jiang W, Avon C, Dowling TC, Shao C, Kane M, Hoag SW, Flasar MH, Ting TY, Polli JE. Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs Cimetidine and Acyclovir. Journal of Pharmaceutical Sciences. PMID 26375604 DOI: 10.1002/Jps.24643 |
0.377 |
|
| 2015 |
Raufman JP, Dawson PA, Rao A, Drachenberg CB, Heath J, Shang AC, Hu S, Zhan M, Polli JE, Cheng K. Slc10a2-null mice uncover colon cancer-promoting actions of endogenous fecal bile acids. Carcinogenesis. 36: 1193-200. PMID 26210740 DOI: 10.1093/Carcin/Bgv107 |
0.357 |
|
| 2015 |
Ting TY, Jiang W, Lionberger R, Wong J, Jones JW, Kane MA, Krumholz A, Temple R, Polli JE. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard. Epilepsia. PMID 26201987 DOI: 10.1111/Epi.13095 |
0.308 |
|
| 2015 |
Gajendran J, Krämer J, Shah VP, Langguth P, Polli J, Mehta M, Groot DW, Cristofoletti R, Abrahamsson B, Dressman JB. Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Nifedipine. Journal of Pharmaceutical Sciences. 104: 3289-98. PMID 26149619 DOI: 10.1002/Jps.24560 |
0.384 |
|
| 2015 |
Donovan MD, Polli JE, Langguth P, Tamai I, Vig B, Yu LX. Gordon L. Amidon: Very Sustained Drug Absorption. Journal of Pharmaceutical Sciences. PMID 26053319 DOI: 10.1002/Jps.24523 |
0.309 |
|
| 2015 |
Vaithianathan S, Raman S, Jiang W, Ting TY, Kane MA, Polli JE. Biopharmaceutic Risk Assessment of Brand and Generic Lamotrigine Tablets. Molecular Pharmaceutics. 12: 2436-43. PMID 26001027 DOI: 10.1021/Acs.Molpharmaceut.5B00154 |
0.317 |
|
| 2015 |
Petruševska M, Berglez S, Krisch I, Legen I, Megušar K, Peternel L, Abrahamsson B, Cristofoletti R, Groot DW, Kopp S, Langguth P, Mehta M, Polli JE, Shah VP, Dressman J. Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Levetiracetam. Journal of Pharmaceutical Sciences. PMID 25663270 DOI: 10.1002/Jps.24350 |
0.336 |
|
| 2015 |
Dong Z, Li Q, Guo D, Shu Y, Polli JE. Synthesis and Evaluation of Bile Acid-Ribavirin Conjugates as Prodrugs to Target the Liver. Journal of Pharmaceutical Sciences. PMID 25645375 DOI: 10.1002/Jps.24375 |
0.559 |
|
| 2015 |
Dong Z, Ekins S, Polli JE. A substrate pharmacophore for the human sodium taurocholate co-transporting polypeptide. International Journal of Pharmaceutics. 478: 88-95. PMID 25448570 DOI: 10.1016/J.Ijpharm.2014.11.022 |
0.611 |
|
| 2015 |
Raufman J, Dawson P, Rao A, Drachenberg C, Shang AC, Hu S, Zhan M, Polli J, Cheng K. Tu1978 Slcl0a2-Null Mice Uncover Colon Cancer-Promoting Actions of Endogenous Fecal Bile Acids Gastroenterology. 148: S-951. DOI: 10.1016/S0016-5085(15)33245-5 |
0.305 |
|
| 2014 |
Charoo N, Cristofoletti R, Graham A, Lartey P, Abrahamsson B, Groot DW, Kopp S, Langguth P, Polli J, Shah VP, Dressman J. Biowaiver monograph for immediate-release solid oral dosage forms: fluconazole. Journal of Pharmaceutical Sciences. 103: 3843-58. PMID 25312492 DOI: 10.1002/Jps.24181 |
0.362 |
|
| 2014 |
Selen A, Dickinson PA, Müllertz A, Crison JR, Mistry HB, Cruañes MT, Martinez MN, Lennernäs H, Wigal TL, Swinney DC, Polli JE, Serajuddin AT, Cook JA, Dressman JB. The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance. Journal of Pharmaceutical Sciences. 103: 3377-97. PMID 25256402 DOI: 10.1002/Jps.24162 |
0.355 |
|
| 2014 |
Dong Z, Ekins S, Polli JE. Quantitative NTCP pharmacophore and lack of association between DILI and NTCP Inhibition. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 66: 1-9. PMID 25220493 DOI: 10.1016/J.Ejps.2014.09.005 |
0.58 |
|
| 2014 |
Vivian D, Polli JE. Synthesis and in vitro evaluation of bile acid prodrugs of floxuridine to target the liver. International Journal of Pharmaceutics. 475: 597-604. PMID 25219859 DOI: 10.1016/J.Ijpharm.2014.09.014 |
0.635 |
|
| 2014 |
Vivian D, Cheng K, Khurana S, Xu S, Dawson PA, Raufman JP, Polli JE. Design and evaluation of a novel trifluorinated imaging agent for assessment of bile acid transport using fluorine magnetic resonance imaging. Journal of Pharmaceutical Sciences. 103: 3782-92. PMID 25196788 DOI: 10.1002/Jps.24131 |
0.665 |
|
| 2014 |
Vivian D, Polli JE. Mechanistic interpretation of conventional Michaelis-Menten parameters in a transporter system. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 64: 44-52. PMID 25169756 DOI: 10.1016/J.Ejps.2014.08.007 |
0.656 |
|
| 2014 |
Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, Woodcock J. Understanding pharmaceutical quality by design. The Aaps Journal. 16: 771-83. PMID 24854893 DOI: 10.1208/S12248-014-9598-3 |
0.32 |
|
| 2014 |
Dahan A, Wolk O, Zur M, Amidon GL, Abrahamsson B, Cristofoletti R, Groot DW, Kopp S, Langguth P, Polli JE, Shah VP, Dressman JB. Biowaiver monographs for immediate-release solid oral dosage forms: codeine phosphate. Journal of Pharmaceutical Sciences. 103: 1592-600. PMID 24788239 DOI: 10.1002/Jps.23977 |
0.382 |
|
| 2014 |
Vivian D, Cheng K, Khurana S, Xu S, Kriel EH, Dawson PA, Raufman JP, Polli JE. In vivo performance of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile acid transport. Molecular Pharmaceutics. 11: 1575-82. PMID 24708306 DOI: 10.1021/Mp400740C |
0.66 |
|
| 2014 |
Gandhi SV, Rodriguez W, Khan M, Polli JE. Considerations for a Pediatric Biopharmaceutics Classification System (BCS): application to five drugs. Aaps Pharmscitech. 15: 601-11. PMID 24557773 DOI: 10.1208/S12249-014-0084-0 |
0.343 |
|
| 2014 |
Charoo NA, Shamsher AA, Lian LY, Abrahamsson B, Cristofoletti R, Groot DW, Kopp S, Langguth P, Polli J, Shah VP, Dressman J. Biowaiver monograph for immediate-release solid oral dosage forms: bisoprolol fumarate. Journal of Pharmaceutical Sciences. 103: 378-91. PMID 24382794 DOI: 10.1002/Jps.23817 |
0.318 |
|
| 2014 |
Garzel B, Yang H, Zhang L, Huang SM, Polli JE, Wang H. The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 42: 318-22. PMID 24335466 DOI: 10.1124/Dmd.113.054189 |
0.388 |
|
| 2014 |
Shohin IE, Kulinich JI, Ramenskaya GV, Abrahamsson B, Kopp S, Langguth P, Polli JE, Shah VP, Groot DW, Barends DM, Dressman JB. Biowaiver monographs for immediate release solid oral dosage forms: piroxicam. Journal of Pharmaceutical Sciences. 103: 367-77. PMID 24301077 DOI: 10.1002/Jps.23799 |
0.39 |
|
| 2014 |
Van Buskirk GA, Shah V, Yacobi A, Bolger MB, Chittenden J, Davit BM, Destefano A, Dressman J, Duan JZ, Ganes DA, González MA, Gray V, Kakhi M, Li R, Mirza T, ... Polli JE, et al. Application of IVIVC in formulation development Dissolution Technologies. 21: 51-58. DOI: 10.14227/Dt210214P51 |
0.315 |
|
| 2014 |
Vivian D, Cheng K, Khurana S, Xu S, Kriel EH, Dawson P, Polli J, Raufman J. Su2017 In Vivo Performance of a Novel Fluorinated Magnetic Resonance Imaging Agent for Functional Analysis of Bile Acid Transport Gastroenterology. 146. DOI: 10.1016/S0016-5085(14)61896-5 |
0.656 |
|
| 2013 |
Raufman JP, Xu S, Cheng K, Khurana S, Vivian D, Shi D, Gullapalli R, Polli J. Phrygian Cap Appearance of a Mouse Gallbladder on Magnetic Resonance Imaging. Journal of Veterinary Science & Medical Diagnosis. 2. PMID 24371838 DOI: 10.4172/2325-9590.1000110 |
0.583 |
|
| 2013 |
Li Q, Guo D, Dong Z, Zhang W, Zhang L, Huang SM, Polli JE, Shu Y. Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs). Toxicology and Applied Pharmacology. 273: 100-9. PMID 24001450 DOI: 10.1016/J.Taap.2013.08.024 |
0.525 |
|
| 2013 |
Soares KC, Rediguieri CF, Souza J, Serra CH, Abrahamsson B, Groot DW, Kopp S, Langguth P, Polli JE, Shah VP, Dressman J. Biowaiver monographs for immediate-release solid oral dosage forms: Zidovudine (azidothymidine). Journal of Pharmaceutical Sciences. 102: 2409-23. PMID 23754446 DOI: 10.1002/Jps.23624 |
0.383 |
|
| 2013 |
Li Q, Yang H, Peng X, Guo D, Dong Z, Polli JE, Shu Y. Ischemia/Reperfusion-inducible protein modulates the function of organic cation transporter 1 and multidrug and toxin extrusion 1. Molecular Pharmaceutics. 10: 2578-87. PMID 23651427 DOI: 10.1021/Mp400013T |
0.541 |
|
| 2013 |
Claro da Silva T, Polli JE, Swaan PW. The solute carrier family 10 (SLC10): beyond bile acid transport. Molecular Aspects of Medicine. 34: 252-69. PMID 23506869 DOI: 10.1016/J.Mam.2012.07.004 |
0.379 |
|
| 2013 |
Dong Z, Ekins S, Polli JE. Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP). Molecular Pharmaceutics. 10: 1008-19. PMID 23339484 DOI: 10.1021/Mp300453K |
0.601 |
|
| 2013 |
Vivian D, Cheng K, Khurana S, Xu S, Whiterock V, Witter D, Lentz KA, Santone KS, Raufman JP, Polli JE. Design and characterization of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile Acid transporter activity. Pharmaceutical Research. 30: 1240-51. PMID 23319170 DOI: 10.1007/S11095-012-0963-6 |
0.761 |
|
| 2013 |
Cristofoletti R, Nair A, Abrahamsson B, Groot DW, Kopp S, Langguth P, Polli JE, Shah VP, Dressman JB. Biowaiver monographs for immediate release solid oral dosage forms: efavirenz. Journal of Pharmaceutical Sciences. 102: 318-29. PMID 23175470 DOI: 10.1002/Jps.23380 |
0.335 |
|
| 2012 |
Ekins S, Polli JE, Swaan PW, Wright SH. Computational modeling to accelerate the identification of substrates and inhibitors for transporters that affect drug disposition Clinical Pharmacology and Therapeutics. 92: 661-665. PMID 23010651 DOI: 10.1038/Clpt.2012.164 |
0.423 |
|
| 2012 |
Nair A, Abrahamsson B, Barends DM, Groot DW, Kopp S, Polli JE, Shah VP, Dressman JB. Biowaiver monographs for immediate release solid oral dosage forms: amodiaquine hydrochloride. Journal of Pharmaceutical Sciences. 101: 4390-401. PMID 22949374 DOI: 10.1002/Jps.23312 |
0.353 |
|
| 2012 |
Shohin IE, Kulinich JI, Ramenskaya GV, Abrahamsson B, Kopp S, Langguth P, Polli JE, Shah VP, Groot DW, Barends DM, Dressman JB. Biowaiver monographs for immediate-release solid oral dosage forms: ketoprofen. Journal of Pharmaceutical Sciences. 101: 3593-603. PMID 22786667 DOI: 10.1002/Jps.23233 |
0.396 |
|
| 2012 |
Nair AK, Anand O, Chun N, Conner DP, Mehta MU, Nhu DT, Polli JE, Yu LX, Davit BM. Statistics on BCS classification of generic drug products approved between 2000 and 2011 in the USA. The Aaps Journal. 14: 664-6. PMID 22718306 DOI: 10.1208/S12248-012-9384-Z |
0.364 |
|
| 2012 |
Polli JE, Cook JA, Davit BM, Dickinson PA, Argenti D, Barbour N, García-Arieta A, Geoffroy JM, Hartauer K, Li S, Mitra A, Muller FX, Purohit V, Sanchez-Felix M, Skoug JW, et al. Summary workshop report: Facilitating oral product development and reducing regulatory burden through novel approaches to assess bioavailability/bioequivalence. The Aaps Journal. 14: 627-38. PMID 22684402 DOI: 10.1208/S12248-012-9376-Z |
0.323 |
|
| 2012 |
Dressman JB, Nair A, Abrahamsson B, Barends DM, Groot DW, Kopp S, Langguth P, Polli JE, Shah VP, Zimmer M. Biowaiver monograph for immediate-release solid oral dosage forms: acetylsalicylic acid. Journal of Pharmaceutical Sciences. 101: 2653-67. PMID 22674043 DOI: 10.1002/Jps.23212 |
0.355 |
|
| 2012 |
Kolhatkar V, Polli JE. Structural requirements of bile acid transporters: C-3 and C-7 modifications of steroidal hydroxyl groups. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 46: 86-99. PMID 22387310 DOI: 10.1016/J.Ejps.2012.02.012 |
0.733 |
|
| 2012 |
González PM, Hussainzada N, Swaan PW, Mackerell AD, Polli JE. Putative irreversible inhibitors of the human sodium-dependent bile acid transporter (hASBT; SLC10A2) support the role of transmembrane domain 7 in substrate binding/translocation. Pharmaceutical Research. 29: 1821-31. PMID 22354836 DOI: 10.1007/S11095-012-0706-8 |
0.313 |
|
| 2012 |
Ekins S, Diao L, Polli JE. A substrate pharmacophore for the human organic cation/carnitine transporter identifies compounds associated with rhabdomyolysis. Molecular Pharmaceutics. 9: 905-13. PMID 22339151 DOI: 10.1021/Mp200438V |
0.385 |
|
| 2012 |
Nair A, Abrahamsson B, Barends DM, Groot DW, Kopp S, Polli JE, Shah VP, Dressman JB. Biowaiver monographs for immediate-release solid oral dosage forms: primaquine phosphate. Journal of Pharmaceutical Sciences. 101: 936-45. PMID 22161739 DOI: 10.1002/Jps.23006 |
0.358 |
|
| 2012 |
Kolhatkar V, Diao L, Acharya C, Mackerell AD, Polli JE. Identification of novel nonsteroidal compounds as substrates or inhibitors of hASBT. Journal of Pharmaceutical Sciences. 101: 116-26. PMID 22109685 DOI: 10.1002/Jps.22728 |
0.747 |
|
| 2012 |
Strauch S, Dressman JB, Shah VP, Kopp S, Polli JE, Barends DM. Biowaiver monographs for immediate-release solid oral dosage forms: quinine sulfate. Journal of Pharmaceutical Sciences. 101: 499-508. PMID 22081435 DOI: 10.1002/Jps.22810 |
0.371 |
|
| 2012 |
Vivian D, Cheng K, Khurana S, Raufman J, Polli J. 291 Development and Testing of a Novel Fluorinated Bile Acid for Detection of Bile Acid Malabsorption by Magnetic Resonance Imaging (MRI) Gastroenterology. 142: S-910. DOI: 10.1016/S0016-5085(12)63531-8 |
0.63 |
|
| 2011 |
da Silva TC, Hussainzada N, Khantwal CM, Polli JE, Swaan PW. Transmembrane helix 1 contributes to substrate translocation and protein stability of bile acid transporter SLC10A2. The Journal of Biological Chemistry. 286: 27322-32. PMID 21646357 DOI: 10.1074/Jbc.M110.217802 |
0.383 |
|
| 2011 |
Raufman JP, Xu S, Cheng K, Khurana S, Johnson D, Shao C, Kane MA, Shi D, Gullapalli R, Polli J. In vivo magnetic resonance imaging to detect biliary excretion of 19F-labeled drug in mice. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 736-9. PMID 21270105 DOI: 10.1124/Dmd.110.037358 |
0.336 |
|
| 2011 |
Rais R, Fletcher S, Polli JE. Synthesis and in vitro evaluation of gabapentin prodrugs that target the human apical sodium-dependent bile acid transporter (hASBT). Journal of Pharmaceutical Sciences. 100: 1184-95. PMID 20848648 DOI: 10.1002/Jps.22332 |
0.664 |
|
| 2011 |
Acharya C, Coop A, Polli JE, Mackerell AD. Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach. Current Computer-Aided Drug Design. 7: 10-22. PMID 20807187 DOI: 10.2174/157340911793743547 |
0.341 |
|
| 2010 |
Zheng X, Pan Y, Acharya C, Swaan PW, Polli JE. Structural requirements of the ASBT by 3D-QSAR analysis using aminopyridine conjugates of chenodeoxycholic acid. Bioconjugate Chemistry. 21: 2038-48. PMID 20968316 DOI: 10.1021/Bc100273W |
0.641 |
|
| 2010 |
Rais R, Acharya C, MacKerell AD, Polli JE. Structural determinants for transport across the intestinal bile acid transporter using C-24 bile acid conjugates Molecular Pharmaceutics. 7: 2240-2254. PMID 20939504 DOI: 10.1021/Mp100233V |
0.641 |
|
| 2010 |
Diao L, Ekins S, Polli JE. Quantitative structure activity relationship for inhibition of human organic cation/carnitine transporter. Molecular Pharmaceutics. 7: 2120-31. PMID 20831193 DOI: 10.1021/Mp100226Q |
0.42 |
|
| 2010 |
Cook JA, Davit BM, Polli JE. Impact of Biopharmaceutics Classification System-based biowaivers. Molecular Pharmaceutics. 7: 1539-44. PMID 20735084 DOI: 10.1021/Mp1001747 |
0.331 |
|
| 2010 |
Kolhatkar V, Polli JE. Reliability of inhibition models to correctly identify type of inhibition. Pharmaceutical Research. 27: 2433-45. PMID 20711748 DOI: 10.1007/S11095-010-0236-1 |
0.704 |
|
| 2010 |
Zheng X, Polli JE. Synthesis and in vitro evaluation of potential sustained release prodrugs via targeting ASBT. International Journal of Pharmaceutics. 396: 111-8. PMID 20600720 DOI: 10.1016/J.Ijpharm.2010.06.039 |
0.618 |
|
| 2010 |
Zheng X, Diao L, Ekins S, Polli JE. Why we should be vigilant: drug cytotoxicity observed with in vitro transporter inhibition studies. Biochemical Pharmacology. 80: 1087-92. PMID 20599790 DOI: 10.1016/J.Bcp.2010.06.012 |
0.654 |
|
| 2010 |
Zheng X, Polli J. Identification of inhibitor concentrations to efficiently screen and measure inhibition Ki values against solute carrier transporters. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 41: 43-52. PMID 20553862 DOI: 10.1016/J.Ejps.2010.05.013 |
0.567 |
|
| 2010 |
Rais R, Acharya C, Tririya G, MacKerell AD, Polli JE. Molecular switch controlling the binding of anionic bile acid conjugates to human apical sodium-dependent bile acid transporter Journal of Medicinal Chemistry. 53: 4749-4760. PMID 20504026 DOI: 10.1021/Jm1003683 |
0.602 |
|
| 2010 |
Tompkins L, Lynch C, Haidar S, Polli J, Wang H. Effects of commonly used excipients on the expression of CYP3A4 in colon and liver cells. Pharmaceutical Research. 27: 1703-12. PMID 20503067 DOI: 10.1007/S11095-010-0170-2 |
0.32 |
|
| 2010 |
Diao L, Shu Y, Polli JE. Uptake of pramipexole by human organic cation transporters. Molecular Pharmaceutics. 7: 1342-7. PMID 20496886 DOI: 10.1021/Mp100036B |
0.406 |
|
| 2010 |
Bahadduri PM, Polli JE, Swaan PW, Ekins S. Targeting drug transporters - combining in silico and in vitro approaches to predict in vivo. Methods in Molecular Biology (Clifton, N.J.). 637: 65-103. PMID 20419430 DOI: 10.1007/978-1-60761-700-6_4 |
0.399 |
|
| 2010 |
Teksin ZS, Seo PR, Polli JE. Comparison of drug permeabilities and BCS classification: three lipid-component PAMPA system method versus Caco-2 monolayers. The Aaps Journal. 12: 238-41. PMID 20224985 DOI: 10.1208/S12248-010-9176-2 |
0.327 |
|
| 2009 |
Zheng X, Ekins S, Raufman JP, Polli JE. Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter. Molecular Pharmaceutics. 6: 1591-603. PMID 19673539 DOI: 10.1021/Mp900163D |
0.648 |
|
| 2009 |
Diao L, Ekins S, Polli JE. Novel inhibitors of human organic cation/carnitine transporter (hOCTN2) via computational modeling and in vitro testing. Pharmaceutical Research. 26: 1890-900. PMID 19437106 DOI: 10.1007/S11095-009-9905-3 |
0.353 |
|
| 2009 |
Chuasuwan B, Binjesoh V, Polli JE, Zhang H, Amidon GL, Junginger HE, Midha KK, Shah VP, Stavchansky S, Dressman JB, Barends DM. Biowaiver monographs for immediate release solid oral dosage forms: Diclofenac sodium and diclofenac potassium Journal of Pharmaceutical Sciences. 98: 1206-1219. PMID 18752289 DOI: 10.1002/Jps.21525 |
0.365 |
|
| 2008 |
Rais R, Gonzalez PM, Zheng X, Wring SA, Polli JE. Method to screen substrates of apical sodium-dependent bile acid transporter. The Aaps Journal. 10: 596-605. PMID 19085111 DOI: 10.1208/S12248-008-9069-9 |
0.681 |
|
| 2008 |
Acharya C, Seo PR, Polli JE, MacKerell AD. Computational model for predicting chemical substituent effects on passive drug permeability across parallel artificial membranes Molecular Pharmaceutics. 5: 818-828. PMID 18710255 DOI: 10.1021/Mp800035H |
0.393 |
|
| 2008 |
Polli JE, Abrahamsson BS, Yu LX, Amidon GL, Baldoni JM, Cook JA, Fackler P, Hartauer K, Johnston G, Krill SL, Lipper RA, Malick WA, Shah VP, Sun D, Winkle HN, et al. Summary workshop report: bioequivalence, biopharmaceutics classification system, and beyond. The Aaps Journal. 10: 373-9. PMID 18679807 DOI: 10.1208/S12248-008-9040-9 |
0.351 |
|
| 2008 |
Polli JE. In vitro studies are sometimes better than conventional human pharmacokinetic in vivo studies in assessing bioequivalence of immediate-release solid oral dosage forms. The Aaps Journal. 10: 289-99. PMID 18500564 DOI: 10.1208/S12248-008-9027-6 |
0.397 |
|
| 2008 |
Benet LZ, Amidon GL, Barends DM, Lennernäs H, Polli JE, Shah VP, Stavchansky SA, Yu LX. The use of BDDCS in classifying the permeability of marketed drugs. Pharmaceutical Research. 25: 483-8. PMID 18236138 DOI: 10.1007/S11095-007-9523-X |
0.344 |
|
| 2007 |
Khandelwal A, Bahadduri PM, Chang C, Polli JE, Swaan PW, Ekins S. Computational models to assign biopharmaceutics drug disposition classification from molecular structure. Pharmaceutical Research. 24: 2249-62. PMID 17846869 DOI: 10.1007/S11095-007-9435-9 |
0.348 |
|
| 2007 |
González-Alvarez I, Fernández-Teruel C, Casabó-Alós VG, Garrigues TM, Polli JE, Ruiz-García A, Bermejo M. In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation with in vitro results. Biopharmaceutics & Drug Disposition. 28: 229-39. PMID 17410527 DOI: 10.1002/Bdd.548 |
0.346 |
|
| 2007 |
Balakrishnan A, Hussainzada N, Gonzalez P, Bermejo M, Swaan PW, Polli JE. Bias in estimation of transporter kinetic parameters from overexpression systems: Interplay of transporter expression level and substrate affinity. The Journal of Pharmacology and Experimental Therapeutics. 320: 133-44. PMID 17038509 DOI: 10.1124/Jpet.106.107433 |
0.326 |
|
| 2006 |
Teksin ZS, Hom K, Balakrishnan A, Polli JE. Ion pair-mediated transport of metoprolol across a three lipid-component PAMPA system. Journal of Controlled Release : Official Journal of the Controlled Release Society. 116: 50-7. PMID 17049402 DOI: 10.1016/J.Jconrel.2006.08.020 |
0.313 |
|
| 2006 |
Chang C, Bahadduri PM, Polli JE, Swaan PW, Ekins S. Rapid identification of P-glycoprotein substrates and inhibitors. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34: 1976-84. PMID 16997908 DOI: 10.1124/Dmd.106.012351 |
0.372 |
|
| 2006 |
Balakrishnan A, Wring SA, Polli JE. Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation. Pharmaceutical Research. 23: 1451-9. PMID 16783481 DOI: 10.1007/S11095-006-0219-4 |
0.462 |
|
| 2006 |
Seo PR, Teksin ZS, Kao JP, Polli JE. Lipid composition effect on permeability across PAMPA. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 29: 259-68. PMID 16781125 DOI: 10.1016/J.Ejps.2006.04.012 |
0.319 |
|
| 2006 |
Balakrishnan A, Wring SA, Coop A, Polli JE. Influence of charge and steric bulk in the C-24 region on the interaction of bile acids with human apical sodium-dependent bile acid transporter. Molecular Pharmaceutics. 3: 282-92. PMID 16749860 DOI: 10.1021/Mp0600135 |
0.401 |
|
| 2006 |
Balakrishnan A, Polli JE. Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target. Molecular Pharmaceutics. 3: 223-30. PMID 16749855 DOI: 10.1021/Mp060022D |
0.438 |
|
| 2006 |
Polli JE. Bile acid disposition and drug pharmacokinetic implications Molecular Pharmaceutics. 3: 197. DOI: 10.1021/Mp0600440 |
0.419 |
|
| 2005 |
Balakrishnan A, Sussman DJ, Polli JE. Development of stably transfected monolayer overexpressing the human apical sodium-dependent bile acid transporter (hASBT). Pharmaceutical Research. 22: 1269-80. PMID 16078136 DOI: 10.1007/S11095-005-5274-8 |
0.444 |
|
| 2004 |
Tolle-Sander S, Lentz KA, Maeda DY, Coop A, Polli JE. Increased acyclovir oral bioavailability via a bile acid conjugate. Molecular Pharmaceutics. 1: 40-8. PMID 15832499 DOI: 10.1021/Mp034010T |
0.715 |
|
| 2004 |
Balakrishnan A, Rege BD, Amidon GL, Polli JE. Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity. Journal of Pharmaceutical Sciences. 93: 2064-75. PMID 15236455 DOI: 10.1002/Jps.20118 |
0.315 |
|
| 2003 |
Tolle-Sander S, Grill A, Joshi H, Kapil R, Persiani S, Polli JE. Characterization of dexloxiglumide in vitro biopharmaceutical properties and active transport. Journal of Pharmaceutical Sciences. 92: 1968-80. PMID 14502537 DOI: 10.1002/Jps.10428 |
0.353 |
|
| 2002 |
Rege BD, Kao JP, Polli JE. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 16: 237-46. PMID 12208453 DOI: 10.1016/S0928-0987(02)00055-6 |
0.381 |
|
| 2002 |
Yu LX, Amidon GL, Polli JE, Zhao H, Mehta MU, Conner DP, Shah VP, Lesko LJ, Chen ML, Lee VH, Hussain AS. Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharmaceutical Research. 19: 921-5. PMID 12180542 DOI: 10.1023/A:1016473601633 |
0.357 |
|
| 2001 |
Rege BD, Yu Lawrence X, Hussain AS, Polli JE. Effect of common excipients on Caco-2 transport of low-permeability drugs Journal of Pharmaceutical Sciences. 90: 1776-1786. PMID 11745735 DOI: 10.1002/Jps.1127 |
0.429 |
|
| 2001 |
Gharat L, Taneja R, Weerapreeyakul N, Rege B, Polli J, Chikhale PJ. Targeted drug delivery systems 6: Intracellular bioreductive activation, uptake and transport of an anticancer drug delivery system across intestinal Caco-2 cell monolayers. International Journal of Pharmaceutics. 219: 1-10. PMID 11337161 DOI: 10.1016/S0378-5173(01)00599-3 |
0.337 |
|
| 2000 |
Lentz KA, Polli JW, Wring SA, Humphreys JE, Polli JE. Influence of passive permeability on apparent P-glycoprotein kinetics. Pharmaceutical Research. 17: 1456-60. PMID 11303953 DOI: 10.1023/A:1007692622216 |
0.658 |
|
| 2000 |
Lentz KA, Hayashi J, Lucisano LJ, Polli JE. Development of a more rapid, reduced serum culture system for Caco-2 monolayers and application to the biopharmaceutics classification system. International Journal of Pharmaceutics. 200: 41-51. PMID 10845684 DOI: 10.1016/S0378-5173(00)00334-3 |
0.663 |
|
| 1999 |
Ginski MJ, Taneja R, Polli JE. Prediction of dissolution-absorption relationships from a continuous dissolution/Caco-2 system Aaps Pharmsci [Electronic Resource]. 1. PMID 11741200 DOI: 10.1208/Ps010203 |
0.33 |
|
| 1999 |
Ginski MJ, Polli JE. Prediction of dissolution-absorption relationships from a dissolution/Caco-2 system International Journal of Pharmaceutics. 177: 117-125. PMID 10205608 DOI: 10.1016/S0378-5173(98)00330-5 |
0.325 |
|
| 1998 |
Polli JE, Ginski MJ. Human drug absorption kinetics and comparison to Caco-2 monolayer permeabilities Pharmaceutical Research. 15: 47-52. PMID 9487545 DOI: 10.1023/A:1011992518592 |
0.386 |
|
| 1997 |
Polli JE. In vitro-in vivo relationships of several 'immediate' release tablets containing a low permeability drug Advances in Experimental Medicine and Biology. 423: 191-198. PMID 9269495 DOI: 10.1007/978-1-4684-6036-0_17 |
0.365 |
|
| 1997 |
Polli JE, Rekhi GS, Augsburger LL, Shah VP. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets Journal of Pharmaceutical Sciences. 86: 690-700. PMID 9188051 DOI: 10.1021/Js960473X |
0.324 |
|
| Show low-probability matches. |